Cardiac Risk: Not So Simple

od Aberg, Judith A., Ribaudo, Heather
Izdano 2010

The use of the Restricted Mean Survival Time as a treatment measure in HIV/AIDS clinical trial: reanalysis of the ACTG A5257 trial

od Abulizi, Xianmixikemaier, Ribaudo, Heather J., Flandre, Philippe
Izdano u J Acquir Immune Defic Syndr (2019)

Instantaneous Inhibitory Potential is Similar to Inhibitory Quotient at Predicting HIV-1 Response to Antiretroviral Therapy

od Henrich, Timothy J., Ribaudo, Heather, Kuritzkes, Daniel R.
Izdano 2010

Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators

od Grinspoon, Steven K, Douglas, Pamela S, Hoffmann, Udo, Ribaudo, Heather J
Izdano u J Infect Dis (2020)

Modeling Clinical Endpoints as a Function of Time of Switch to Second-line ART With Incomplete Data on Switching Times

od Johnson, Brent A., Ribaudo, Heather, Gulick, Roy M., Eron, Joseph J.
Izdano 2013

The Relationship of CCR5 Antagonists to CD4+ T-Cell Gain: A Meta-Regression of Recent Clinical Trials in Treatment-Experienced HIV-Infected Patients

od Wilkin, Timothy J., Ribaudo, Heather R., Tenorio, Allan R., Gulick, Roy M.
Izdano 2010

Antiretroviral Regimen and Suboptimal Medication Adherence Are Associated With Low-Level Human Immunodeficiency Virus Viremia

od Konstantopoulos, Christina, Ribaudo, Heather, Ragland, Kathleen, Bangsberg, David R., Li, Jonathan Z.
Izdano u Open Forum Infect Dis (2015)

Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095

od Li, Li, Eron, Joseph J., Ribaudo, Heather, Gulick, Roy M., Johnson, Brent A.
Izdano 2012

Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy

od Bhagwat, Priya, Kapadia, Shashi N, Ribaudo, Heather J, Gulick, Roy M, Currier, Judith S
Izdano u Open Forum Infect Dis (2019)

Long-Term Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals (ACTG 5097s)

od Clifford, David B., Evans, Scott, Yang, Yijun, Acosta, Edward P., Ribaudo, Heather, Gulick, Roy M.
Izdano 2009

Incomplete Adherence to Antiretroviral Therapy is Associated with Higher Levels of Residual HIV-1 Viremia

od Li, Jonathan Z., Gallien, Sebastien, Ribaudo, Heather, Heisey, Andrea, Bangsberg, David R., Kuritzkes, Daniel R.
Izdano 2014

Effects of HIV Infection on Arterial Endothelial Function: Results from a Large Pooled Cohort Analysis

od Stein, James H., Kime, Noah, Korcarz, Claudia E., Ribaudo, Heather, Currier, Judith S., Delaney, Joseph C.
Izdano u Arterioscler Thromb Vasc Biol (2020)

Antiretroviral Drug Resistance in HIV-1–Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy

od Taiwo, Babafemi, Gallien, Sebastien, Aga, Evgenia, Ribaudo, Heather, Haubrich, Richard, Kuritzkes, Daniel R., Eron, Joseph J.
Izdano 2011

Hyperlipidemia in HIV-Infected Patients on Lopinavir/Ritonavir Monotherapy in Resource-Limited Settings

od Matoga, Mitch M., Hosseinipour, Mina C., Aga, Evgenia, Ribaudo, Heather J., Kumarasamy, Nagalingeswaran, Bartlett, John, Hughes, Michael D.
Izdano u Antivir Ther (2016)

Substitution of Nevirapine because of Efavirenz Toxicity in AIDS Clinical Trials Group A5095

od Schouten, Jeffrey T., Krambrink, Amy, Ribaudo, Heather J., Kmack, Anne, Webb, Nancy, Shikuma, Cecilia, Kuritzkes, Daniel R., Gulick, Roy M.
Izdano 2010

Drug Susceptibility and Resistance Mutations After First-Line Failure in Resource Limited Settings

od Wallis, Carole L., Aga, Evgenia, Ribaudo, Heather, Saravanan, Shanmugam, Norton, Michael, Stevens, Wendy, Kumarasamy, Nagalingeswaran, Bartlett, John, Katzenstein, David
Izdano 2014

Pharmacokinetics of Indinavir and Nelfinavir in Treatment-Naive, Human Immunodeficiency Virus-Infected Subjects

od DiCenzo, Robert, Forrest, Alan, Fischl, Margaret A., Collier, Ann, Feinberg, Judith, Ribaudo, Heather, DiFrancecso, Robin, Morse, Gene D.
Izdano 2004

Ultrasensitive Detection of Minor Drug-Resistant Variants for HIV After Nevirapine Exposure Using Allele-Specific PCR: Clinical Significance

od Rowley, Christopher F., Boutwell, Christian L., Lee, Esther J., MacLeod, Iain J., Ribaudo, Heather J., Essex, M., Lockman, Shahin
Izdano 2010

1609 Plasma markers of immune activation likely reflect related but distinct processes of cellular immune activation in HIV-infected persons before and after suppression of viremia...

od Kelesidis, Theodoros, Moser, Carlee, Mccomsey, Grace A., Brown, Todd, Ribaudo, Heather, Tran, Thuy Tien T, Yang, Otto, Stein, James, Currier, Judith
Izdano u Open Forum Infect Dis (2014)

Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia

od Vardhanabhuti, Saran, Ribaudo, Heather J., Landovitz, Raphael J., Ofotokun, Ighovwerha, Lennox, Jeffrey L., Currier, Judith S., Olson, Lana M., Haas, David W.
Izdano u Open Forum Infect Dis (2015)